Your browser doesn't support javascript.
loading
Comprehensive screening for drugs that modify radiation-induced immune responses.
Okumura, Masayuki; Du, Junyan; Kageyama, Shun-Ichiro; Yamashita, Riu; Hakozaki, Yumi; Motegi, Atsushi; Hojo, Hidehiro; Nakamura, Masaki; Hirano, Yasuhiro; Okuma, Yusuke; Okuma, Hitomi S; Tsuchihara, Katsuya; Akimoto, Tetsuo.
Afiliação
  • Okumura M; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Du J; Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Kageyama SI; Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Yamashita R; Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Hakozaki Y; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan. skageyam@east.ncc.go.jp.
  • Motegi A; Division of Radiation Oncology and Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan. skageyam@east.ncc.go.jp.
  • Hojo H; Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Nakamura M; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Hirano Y; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Okuma Y; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Okuma HS; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Tsuchihara K; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Akimoto T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Br J Cancer ; 126(12): 1815-1823, 2022 06.
Article em En | MEDLINE | ID: mdl-35184156

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article